AG真人官方

CCEP鈥檚 H1-25 results show resilient top-line and margin expansion despite soft underlying volume. Reported revenue rose to 鈧�10.27bn (+4.5% YoY; +5.3% FX-neutral) with adjusted comparable growth of 1.8% (+2.5% FXN) as the Feb-24 Philippines acquisition annualises. Comparable volume increased 4.1%, but only +0.3% on an adjusted basis due to two fewer selling days; Europe -1.9% was offset by APS +17.1% (+1.5% adj.).

Pricing and mix drove revenue/UC to 鈧�5.36 (+1.1% comparable, +3.8% adj.) and, together with lower restructuring costs, lifted reported operating profit 19.4% to 鈧�1.36bn. Comparable operating profit reached 鈧�1.39bn (+7.3% YoY; +8.0% FXN); diluted EPS was 鈧�1.99 (+15.0%), or 鈧�2.02 on a comparable basis (+2.4%). Interim dividend is 鈧�0.79/share (40% of FY-24 payout).

Cost discipline continued: comparable OPEX edged up 1.3% while cost-of-sales/UC rose 1.6%. Net debt increased to 鈧�10.0bn (vs 鈧�9.7bn at FY-24) after buybacks (鈧�365m) and 鈧�367m dividends. Effective tax rate climbed to 26% (22% LY), weighing on after-tax growth. Sustainability credentials were reaffirmed with CDP 鈥楢鈥� Climate status for a ninth year. Management sees adequate liquidity (鈧�1.8bn undrawn credit line) and reaffirms going-concern status; no updated FY guidance was provided.

Coca-Cola Europacific Partners (CCEP) delivered resilient H1-25 results and maintained FY-25 guidance. Reported revenue rose to 鈧�10.3bn (+4.5%), with FX-neutral growth of 5.3%. Comparable operating profit reached 鈧�1.39bn (+7.3% YoY; reported +19.4%), helped by pricing, mix and lower restructuring charges. Diluted EPS was 鈧�1.99 (+15.0% reported; +3.1% comparable). Volume grew 4.1% on a comparable basis but just 0.3% on an adjusted comparable basis, reflecting weakness in Indonesia and the de-listing of Capri Sun.

• Europe: revenue +2.6%, volume -1.9%; Q2 returned to growth on favourable weather and Easter shift.
• APS: revenue +10.0%, volume +17.1% (adjusted +1.5%); Indonesia drag offset strong Australia and Philippines.
• Cost of sales per unit case +1.6% (comparable) / +3.6% (adj.).
• Comparable free cash flow 鈧�425m (-21% YoY) after 鈧�430m capex and software spend.
• Interim dividend 鈧�0.79/share (40% of FY-24 dividend) and 鈧�1bn buy-back (鈮堚偓460m completed).

FY-25 outlook (FX-neutral, adjusted comparable) reaffirmed: revenue +3-4%, cost of sales/UC 鈮�+2%, operating profit 鈮�+7%, at least 鈧�1.7bn free cash flow, CAPEX 鈮�5% of revenue; FX expected to be a ~200 bps headwind to operating profit. Management cites ongoing productivity initiatives and AI-enabled efficiencies to counter a volatile macro environment.

Transaction summary: Coca-Cola Europacific Partners plc (CCEP) disclosed repurchases of ordinary shares between 29 July and 4 August 2025 under its share buyback Programme announced 14 February 2025. Over five trading dates the Company purchased an aggregate 218,198 ordinary shares (US and London trading venues combined). Purchases were executed from Goldman Sachs & Co. LLC, Goldman Sachs International or affiliates and the repurchased shares will be cancelled.

Programme context and execution: The transactions form part of a Programme under which CCEP expects to repurchase up to EUR 1 billion of ordinary shares. Purchases occurred across US trading venues (Nasdaq and others) and London trading venues (LSE, CBOE Europe BXE/CXE), with notable London activity on 29鈥�31 July and no London purchases reported on 1 and 4 August 2025. VWAPs and per-share price ranges were disclosed per venue and date in the Schedule to the announcement.

Coca-Cola Europacific Partners (CCEP) filed a Form 6-K detailing daily share repurchases executed 22-28 July 2025 under its 鈧�1 billion buy-back programme first announced 14 Feb 2025.

• Shares acquired: 178,163 on US venues (Nasdaq & others) and 80,182 on London venues (LSE, CBOE CXE/BXE), totalling 鈮�258,345 ordinary shares.
• Daily volumes: 49k-53k shares; largest single-day purchase was 53,077 shares on 28 Jul.
• US pricing: VWAP ranged USD 98.16-100.22; high/low band USD 97.50-100.65.
• UK pricing: VWAP ranged GBP 72.76-74.28; high/low band GBP 72.50-75.10.
• All repurchased shares will be cancelled, directly reducing share count and enhancing EPS accretion.

The filing is an operational update only; no new financial guidance or earnings data were provided. Repurchases were conducted through Goldman Sachs entities and remain well within the authorised 鈧�1 billion limit.

Coca-Cola Europacific Partners plc (CCEP) filed a Form 6-K detailing daily purchases of its own shares between 15-21 July 2025 under the 鈧�1 billion buyback programme announced on 14 February 2025.

• Total shares repurchased over the five trading days: 鈮�263,000 ordinary shares (nominal value 鈧�0.01 each), all of which will be cancelled.
• Daily volumes ranged from 51,082 to 54,051 shares; purchases were split between US trading venues (Nasdaq & others) and London venues (LSE, Cboe CXE & BXE).
• Highest prices paid: USD 97.90 and GBP 72.60; lowest: USD 93.65 and GBP 69.90. Volume-weighted average prices generally clustered around USD 94-97 and GBP 70-72.
• Counterparty for all transactions: Goldman Sachs & Co. LLC or affiliates.

The filing contains no earnings data or new guidance; it simply confirms ongoing execution of the authorised buyback, which is intended to enhance shareholder returns by reducing the share count.